Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Windtree Therapeutics Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 12 | 12 | 0 |
| Shares | 121.1K | 208.2K | +87.1K (+71.9%) |
| Value | $151.7K | $197.7K | +$46.0K (+30.3%) |
New holders (4)
Institutions that held Windtree Therapeutics Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 136,518 | $129.5K | 0.00% |
| Vanguard Group Inc | 41,640 | $39.5K | 0.00% |
| Geode Capital Management, LLC | 14,197 | $13.7K | 0.00% |
| US Bancorp | 3 | $3 | 0.00% |
Sold out (4)
Institutions that held Windtree Therapeutics Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Virtu Financial LLC | 42,667 | $54.0K |
| Acadian Asset Management LLC | 31,583 | $39.0K |
| Citadel Advisors LLC | 21,722 | $27.3K |
| Two Sigma Securities, LLC | 16,871 | $21.1K |